140 related articles for article (PubMed ID: 32888740)
1. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers.
Wanlapakorn N; Maertens K; Thongmee T; Srimuan D; Thatsanathorn T; Van Damme P; Leuridan E; Poovorawan Y
Vaccine; 2020 Oct; 38(44):6914-6921. PubMed ID: 32888740
[TBL] [Abstract][Full Text] [Related]
2. Antibody persistence to diphtheria toxoid, tetanus toxoid,
Wanlapakorn N; Sarawanangkoor N; Srimuan D; Thatsanathorn T; Thongmee T; Poovorawan Y
Hum Vaccin Immunother; 2024 Dec; 20(1):2352909. PubMed ID: 38752802
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4-65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany.
Aydin I; May M; Pisano F; Mpofu-Maetzig N; Grode L; Parekh S; Pujari P; Shewale S; Desai S; Sharma H; Rao H; Gautam M; Gairola S; Shaligram U
Vaccine; 2023 Nov; 41(46):6810-6819. PubMed ID: 37827966
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of pertussis, tetanus, and diphtheria antibodies in sera and breast milk from Tdap vaccinated women using a qualified multiplex assay.
Portillo S; Oshinsky J; Williams M; Yoder S; Liang Y; Campbell JD; Laufer MK; Neuzil KM; Edwards KM; Pasetti MF
mSphere; 2024 Apr; 9(4):e0052723. PubMed ID: 38497618
[TBL] [Abstract][Full Text] [Related]
5. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
Skoff TH; Blain AE; Watt J; Scherzinger K; McMahon M; Zansky SM; Kudish K; Cieslak PR; Lewis M; Shang N; Martin SW
Clin Infect Dis; 2017 Nov; 65(12):1977-1983. PubMed ID: 29028938
[TBL] [Abstract][Full Text] [Related]
6. Vaccination during pregnancy and modulation of IgG response to pertussis vaccines in infants: The impact of different vaccine formulations.
Brousseau N; Angers-Goulet ME; Bastien R; Ye L; Sadarangani M; Halperin SA
Vaccine; 2024 Apr; 42(9):2138-2143. PubMed ID: 38461048
[TBL] [Abstract][Full Text] [Related]
7. Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines.
Chokephaibulkit K; Puthanakit T; Chaithongwongwatthana S; Bhat N; Tang Y; Anugulruengkitt S; Chayachinda C; Anuwutnavin S; Lapphra K; Rungmaitree S; Tawan M; Andi-Lolo I; Holt R; Fortuna L; Kerdsomboon C; Yuwaree V; Mansouri S; Thai PH; Innis BL
Vaccine; 2024 Jan; 42(2):383-395. PubMed ID: 38061956
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity at delivery after Tdap vaccination in successive pregnancies.
De Weerdt L; Thiriard A; Leuridan E; Marchant A; Maertens K
Front Immunol; 2024; 15():1360201. PubMed ID: 38464513
[TBL] [Abstract][Full Text] [Related]
9. Comparing the pertussis antibody levels of healthy children immunized with four doses of DTap-IPV/Hib (Pentaxim) combination vaccine and DTaP vaccine in Quzhou, China.
Yin Z; Zheng C; Fang Q; Wen T; Wang S; Li J; Gong X; Xiang Z
Front Immunol; 2022; 13():1055677. PubMed ID: 36685526
[TBL] [Abstract][Full Text] [Related]
10. Prevention of pertussis through adult vaccination.
Suryadevara M; Domachowske JB
Hum Vaccin Immunother; 2015; 11(7):1744-7. PubMed ID: 25912733
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study.
Haidara FC; Tapia MD; Diallo F; Portillo S; Williams M; Traoré A; Rotrosen E; Hensel E; Makowski M; Selamawi S; Powell JA; Kotloff KL; Pasetti MF; Sow SO; Neuzil KM
EClinicalMedicine; 2024 May; 71():102556. PubMed ID: 38586589
[TBL] [Abstract][Full Text] [Related]
12. Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Pertussis in the Newborn in Publicly and Privately Insured Mother-infant Pairs in the United States.
Mott K; Huybrechts KF; Glynn RJ; Mogun H; Hernández-Díaz S
Pediatr Infect Dis J; 2021 Jul; 40(7):681-687. PubMed ID: 33657597
[TBL] [Abstract][Full Text] [Related]
13. Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination.
Gonçalves G; Santos MA; Frade JG; Cunha JS
BMC Public Health; 2007 Jun; 7():109. PubMed ID: 17565697
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of pertussis booster vaccination for adolescents in Japan.
Tanaka M; Okubo R; Hoshi SL; Kondo M
Vaccine; 2024 Mar; 42(8):2081-2088. PubMed ID: 38418340
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and Acceptability about Adult Pertussis Immunization in Korean Women of Childbearing Age.
Ko HS; Jo YS; Kim YH; Park YG; Wie JH; Cheon J; Moon HB; Lee Y; Shin JC
Yonsei Med J; 2015 Jul; 56(4):1071-8. PubMed ID: 26069132
[TBL] [Abstract][Full Text] [Related]
16. Attitudes and behaviors of maternal Tdap vaccination in Panama, Peru, and Colombia: An international cross-sectional study.
McDermid P; Blazek K; Mougin N; Thomson A; Seale H
Vaccine; 2024 Mar; 42(7):1698-1703. PubMed ID: 38355320
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.
Zasada AA; Rastawicki W; Rokosz N; Jagielski M
BMC Infect Dis; 2013 Nov; 13():551. PubMed ID: 24252165
[TBL] [Abstract][Full Text] [Related]
18. Use of tetanus-diphtheria (Td) vaccine in children 4-7 years of age: World Health Organization consultation of experts.
Desai S; Scobie HM; Cherian T; Goodman T;
Vaccine; 2020 May; 38(21):3800-3807. PubMed ID: 31983584
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
